Indian Companies Initiate Buying Vaccines For Employees

Reading Time: 2 minutes

As the government is rushing to get the most vulnerable people vaccinated, most corporations, however, have kept their profiles low when asked whether or not they would secure an early supply of vaccines for their employees.

 

Having said that, there are many companies in India that are planning to buy COVID-19 vaccines for their workers, soon after the government started one of the world’s most far-reaching vaccination drives, beginning from healthcare and other frontline workers.

 

Steel producer Jindal Steel and Power Ltd., autos-to technology amalgamation, Mahindra Group, and consumer goods giant ITC Ltd are in talks with the government as to when the vaccinations can be available for their workers and employees.

 

Amitav Mukherji, the head of corporate HR, said “ITC would certainly like to extend the vaccination to employees… We have approached vaccine manufactures and are in exploratory talks”.

 

The vaccine that is currently used in India is made by Britain’s Oxford University/ AstraZeneca, which is being produced in India by the Serum -Institute, and a government-backed alternative developed by India’s Bharat Biotech.

 

Tata Steel said that it wants its employees to get vaccinated as soon as the shots are commercially available.

 

Needless to say, many Indian factories are still recovering from one of the world’s strictest lockdown last year, which has had many pitfalls including the loss of many workers which led them to migrate back to their villages.

 

“We are reaching out to vaccine manufacturers for bulk supply of doses and will try to get these doses after completion of all frontline Covid warriors’ vaccination”, said Pankaj Lochan, chief human resource officer, JSPL. Mr. Pankaj did not divulge into more details as to whom they have been in talks with or how many doses they are planning to buy.

 

With India being the second-most populous country, it trails only the United States in numbers of Covid-19 infections.

 

 

Source: Economic Times

 

Related Post

Contact Us

Name(Required)
Company Name(Required)
This field is for validation purposes and should be left unchanged.

Contact Us

Name(Required)
Company Name(Required)
This field is for validation purposes and should be left unchanged.

We value your privacy

We use cookies on our website to provide you with the best experience. If you continue browsing, you consent to our use of these cookies. If you like to know more, take a look at our “privacy policy”.